Glaucoma daily living and driving ability check
Part of Brain & nervous system, Eyes & vision clinical trials.
This study tests a questionnaire and assessment tool to better understand how glaucoma affects everyday activities, and possibly driving readiness. It may help clinicians measure impact on daily living and monitor patient needs more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have glaucoma that has been stable for you, followed by Quinze-Vingts
- Your vision test is at least 6/10 in both eyes together
- You can understand and sign consent, and follow the study steps
- You do not have other eye diseases besides glaucoma
- You do not have conditions or medicines that could affect movement, vision, or thinking, and you can read
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to detect early glaucoma by measuring how well you see. If you have early-stage glaucoma or healthy vision, your participation could help improve early diagnosis and treatment.
This study looks at different ways to measure how glaucoma affects your vision over time by comparing visual field results. It may help researchers find better models to track progression so treatment decisions can be made more accurately.
This study looks at whether how far and how much you move around each day is linked to glaucoma and vision field loss in older adults. It may help researchers understand what affects vision changes over time.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This trial compares different visual field test patterns to detect central vision loss in glaucoma patients who already show thinning of retinal cells. The goal is to find which test pattern works best for early detection.
Hear when a new Optic Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.